错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

A type 1 immunity-restricted promoter of the IL−33 receptor gene directs antiviral T-cell responses

  • Tobias M. Brunner,
  • Sebastian Serve,
  • Anna-Friederike Marx,
  • Jelizaveta Fadejeva,
  • Philippe Saikali,
  • Maria Dzamukova,
  • Nayar Durán-Hernández,
  • Christoph Kommer,
  • Frederik Heinrich,
  • Pawel Durek,
  • Gitta A. Heinz,
  • Thomas Höfer,
  • Mir-Farzin Mashreghi,
  • Ralf Kühn,
  • Daniel D. Pinschewer,
  • Max Löhning

摘要

The pleiotropic alarmin interleukin-33 (IL-33) drives type 1, type 2 and regulatory T-cell responses via its receptor ST2. Subset-specific differences in ST2 expression intensity and dynamics suggest that transcriptional regulation is key in orchestrating the context-dependent activity of IL-33–ST2 signaling in T-cell immunity. Here, we identify a previously unrecognized alternative promoter in mice and humans that is located far upstream of the curated ST2-coding gene and drives ST2 expression in type 1 immunity. Mice lacking this promoter exhibit a selective loss of ST2 expression in type 1- but not type 2-biased T cells, resulting in impaired expansion of cytotoxic T cells (CTLs) and T-helper 1 cells upon viral infection. T-cell-intrinsic IL-33 signaling via type 1 promoter-driven ST2 is critical to generate a clonally diverse population of antiviral short-lived effector CTLs. Thus, lineage-specific alternative promoter usage directs alarmin responsiveness in T-cell subsets and offers opportunities for immune cell-specific targeting of the IL-33–ST2 axis in infections and inflammatory diseases.